Mesothelioma Legal Blog

A Florida state appeals court recently denied a motion by the defendant in an asbestos cancer lawsuit to bar testimony from one of its company executives who plaintiffs say would have inside knowledge about the defendant’s history and interactions with asbestos-containing products, as well as its adherence to occupational health and safety laws. The mesothelioma cancer lawsuit names utility company Florida Power & Light Co. as the defendant and accused the business of knowingly exposing the plaintiff to dangerous carcinogens which caused his cancer diagnosis and other health problems.

Being diagnosed with mesothelioma is overwhelming, and navigating the legal process can feel daunting. If you or a loved one has been diagnosed with mesothelioma, seeking financial compensation is essential to cover mounting medical bills and secure your family’s future. Mesothelioma victims and their families typically have two ways to pursue compensation. One can file a lawsuit or seek a payout from an asbestos trust fund, also called a mesothelioma trust fund. If you are wondering which option is right for you, read on to learn more.

For purposes of this article, the mesothelioma victim in this case will be referred to as Mr. J.S., and his wife will be referred to as Mrs. D.S. In a recent ruling, an appellate court rejected Fort Motor Company’s (FMC) attempt to overturn a jury verdict awarding $3.3 million to Mr. J.S., a mesothelioma victim, and his wife, Mrs. D.S. The decision left intact the jury’s decision that the auto manufacturer was negligent in failing to warn about the risks of asbestos in its brake products, which the jury determined were a significant contributing factor to Mr. J.S.’s peritoneal mesothelioma. Mr. J.S.

A New Jersey state jury recently handed down a $2.38 million plaintiff’s verdict in an asbestos cancer lawsuit brought by a man who claimed he developed mesothelioma cancer from years of exposure to asbestos shipped to his workplace by the defendant. The mesothelioma cancer lawsuit named Union Carbide as the defendant, and was eventually carried on by the victim’s widow after he succumbed to the disease which he claimed was caused by the defendant’s negligence. The road to justice was a long one for the victim and his widow, originally filing the mesothelioma cancer lawsuit in June 2011.

Italian researchers from the University of of Salento in Lecce recently published findings from their study of a potentially groundbreaking mesothelioma cancer treatment that could drastically improve the prognosis of patients with what is considered to be one of the more difficult types of cancer to treat. The study researched how well lab rats with particular mesothelioma tumors responded to two experimental drugs, Ptac2S and cisplatin, and whether either of the two treatments could potentially translate into benefits for human patients.

A recent Duke University study published in The American Journal of Surgical Pathology examined hundreds of women diagnosed with diffuse mesothelioma, looking to an analyzing trends among the group which could eventually shed light on new treatment and detection methods. One of the key findings in the mesothelioma cancer study found that women with objective markers were diagnosed with pleural mesothelioma and that their average age of diagnosis was older compared to those diagnosed with another common type of the cancer, peritoneal mesothelioma.